v3.26.1
STOCKHOLDERS EQUITY
 6 Months Ended
Jun. 30, 2026
Equity [Abstract]  
Equity [Text Block]
NOTE 5 – STOCKHOLDERS’ EQUITY
 
The Company has authorized 10,000,000 shares of common stock having a par value of $0.001.
 
Restricted Stock Issuances
 
The table below summarizes the restricted
,
non-trading common stock awards during the six months ended June 30, 2026 and 2025:
 
Restricted
,
Non-Trading Common Stock Awards
Officers and Directors
Six Months Ended June 30
 
2026
 
 
2025
 
 
 
Price
 
 
Shares
 
 
Amount
 
 
 
 
 
Price
 
 
Shares
 
 
Amount
 
Q1
 
 
 
 
 
 
 
 
 
 
 
 
 
Q1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Glenn Simpson
 
$
0.81
 
 
 
90,000
 
 
$
72,900
 
 
 Glenn Simpson
 
 
$
-
 
 
 
-
 
 
$
-
 
Total
 
 
 
 
 
 
90,000
 
 
$
72,900
 
 
 
Total
 
 
 
 
 
 
-
 
 
 
-
 
 
$
-
 
Q2
 
 
 
 
 
 
 
 
 
 
 
 
 
Q2 
 
 
 
 
 
 
 
 
 
 
 
 
 
Glenn Simpson
 
$
0.66
 
 
 
60,000
 
 
$
39,600
 
 
 Glenn Simpson
 
 
$
-
 
 
 
-
 
 
$
-
 
Total
 
 
 
 
 
 
150,000
 
 
$
112,500
 
 
 Total
 
 
 
-
 
 
 
-
 
 
$
-
 
 
The fair value of restricted, non-trading stock awards issued during the six months ended June 30, 2026 was determined based on the closing market price of the Company’s common stock on the grant date. The restricted, non-trading stock awards vested immediately upon grant, and accordingly, the full fair value was recognized as non-cash, restricted stock compensation expense during the period in accordance with ASC 718. Such expense is included in selling, general, and administrative expenses in the accompanying statements of operations. See Note 2 for further information regarding the Company’s non-cash, restricted stock compensation policy.
 
Stock Transactions
 
During the six
 
months
ended June 30, 2026, the Company issued 150,000 shares of restricted, non-trading common stock to Glenn Simpson pursuant to the terms of his employment agreement. The shares had an aggregate fair value of $112,500, based on the quoted OTC market price of the Company’s common stock on the grant dates. Of this amount, $24,300 represented a performance bonus that was accrued during 2025 and settled through the issuance of restricted
,
non-trading common
stock
in 2026. The remaining $88,200 represented compensation expense during the six
 months
ended June 30, 2026. The Company’s common stock
closed at
$0.81 per share on November 17, 2025
,
and $0.66 per share on April 8,
2026, which were the respective grant dates used to determine the fair value of the awards.
 
During the six months ended June 30, 2025, the Company did not issue any shares of restricted, non-trading common stock to officers and directors of the Company.
 
The Company repurchased
 and retired
20,605 shares of its common stock from a s
tock
holder during the six months ended June 30, 2026. The Company repurchased
 and retired
75,000 shares of its common stock from s
tock
holders during the six months ended June 30, 2025.